New hires and promotions in the biopharma industry in Asia-Pacific, including: Adagene, Immutep.

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Directsync Surgical, Jogo Health, Kurin, Olympus.

Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Cerus Endovascular, Curasight, Curium Pharma, Insightec, Personalis, Quipt Home Medical, Smith+Nephew, Stryker, Vivasure.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Convergent, Pathnostics, Urotronic.

Med-tech firms raising money in public or private financings, including: Dariohealth, Dexcom, Opgen.

New hires and promotions in the med-tech industry, including: CS Genetics, Conventus Flower Orthopedics, Corvent Medical, Quantum-Si, Tivic Health Systems.

Regulatory snapshots, including drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations in Asia-Pacific: Atea, Bridge, H. Lundbeck, Hipra Human Health, Invivyd, Moderna, Otsuka, Senhwa, Takeda.

Biopharma happenings in Asia-Pacific, such as deals and partnerships, grants, preclinical data and other news in brief: I-Mab, Sable, Shanghai Liuqiang Medical, Tracon.

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Belief Biomed, Bionomics, Daewoong, I-Mab, Inmagene, Junshi, Lianbio, Olix, Otsuka, Ovid, SAB, Sunovion, Takeda.

Biopharmas in Asia-Pacific raising money in public or private financings: Adcentrx, Albatroz, Biomica, Mesoblast, Mezzion.